IGM Biosciences's total assets for Q3 2024 were $304.51M, a decrease of -9.51% from the previous quarter. IGMS total liabilities were $225.56M for the fiscal quarter, a 5.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.